ATE167181T1 - Naphthylessigsäurederivate als pgez agonisten und antagonisten - Google Patents
Naphthylessigsäurederivate als pgez agonisten und antagonistenInfo
- Publication number
- ATE167181T1 ATE167181T1 AT94309088T AT94309088T ATE167181T1 AT E167181 T1 ATE167181 T1 AT E167181T1 AT 94309088 T AT94309088 T AT 94309088T AT 94309088 T AT94309088 T AT 94309088T AT E167181 T1 ATE167181 T1 AT E167181T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- agonists
- acid derivatives
- antagonists
- pgez
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical class C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- GHRYSOFWKRRLMI-UHFFFAOYSA-N 1-naphthyloxyacetic acid Chemical class C1=CC=C2C(OCC(=O)O)=CC=CC2=C1 GHRYSOFWKRRLMI-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 abstract 1
- 229960002986 dinoprostone Drugs 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
- C07C311/25—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
- C07C311/27—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/28—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34085493 | 1993-12-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE167181T1 true ATE167181T1 (de) | 1998-06-15 |
Family
ID=18340925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94309088T ATE167181T1 (de) | 1993-12-09 | 1994-12-07 | Naphthylessigsäurederivate als pgez agonisten und antagonisten |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5624959A (de) |
| EP (1) | EP0657422B1 (de) |
| KR (1) | KR100191946B1 (de) |
| CN (1) | CN1111612A (de) |
| AT (1) | ATE167181T1 (de) |
| CA (1) | CA2137711A1 (de) |
| DE (1) | DE69410956T2 (de) |
| DK (1) | DK0657422T3 (de) |
| ES (1) | ES2118333T3 (de) |
| GR (1) | GR3027694T3 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6197993B1 (en) | 1996-07-02 | 2001-03-06 | Ono Pharmaceutical Co., Ltd. | Naphthyloxyacetic acid derivatives and a pharmaceutical composition comprising them as an active ingredient |
| EP0845451A4 (de) * | 1995-07-26 | 1999-10-13 | Ono Pharmaceutical Co | Naphthyloxoessigsäure-derivate und medikamente die diese als aktive bestandteile enthalten |
| GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| AU8750298A (en) * | 1997-08-28 | 1999-03-22 | Ono Pharmaceutical Co. Ltd. | Peroxisome proliferator-activated receptor controllers |
| AU741742B2 (en) | 1998-02-24 | 2001-12-06 | Eli Lilly And Company | Sulphonamide derivatives |
| EP1177187B1 (de) | 1999-04-28 | 2007-07-25 | Sanofi-Aventis Deutschland GmbH | Di-aryl-säurederivate als ppar rezeptor liganden |
| GB0124124D0 (en) * | 2001-10-08 | 2001-11-28 | Medical Res Council | Methods of treatment |
| WO2004032964A1 (ja) * | 2002-10-10 | 2004-04-22 | Ono Pharmaceutical Co., Ltd. | アレルギー性疾患治療剤 |
| PT2799427T (pt) * | 2006-07-05 | 2018-10-16 | Fibrotech Therapeutics Pty Ltd | Compostos terapêuticos |
| DE102007013855A1 (de) | 2007-03-20 | 2008-09-25 | Merck Patent Gmbh | Substituierte Tetrahydrochinoline |
| US20080265343A1 (en) * | 2007-04-26 | 2008-10-30 | International Business Machines Corporation | Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof |
| MX372721B (es) * | 2007-12-21 | 2020-05-11 | Certa Therapeutics Pty Ltd | Ánalogos halogenados de agentes antifi-broticos. |
| JP2012500189A (ja) * | 2008-08-15 | 2012-01-05 | エフ．ホフマン−ラ ロシュ アーゲー | ビアリールアミノテトラリン |
| EP2321267A2 (de) * | 2008-08-15 | 2011-05-18 | F. Hoffmann-La Roche AG | Monoaryl-aminotetraline |
| EP2321266A2 (de) | 2008-08-15 | 2011-05-18 | F. Hoffmann-La Roche AG | Substituierte aminotetraline |
| RU2011124149A (ru) | 2008-11-17 | 2012-12-27 | Ф.Хоффманн-Ля Рош Аг | Нафтилуксусные кислоты |
| CN102216273A (zh) | 2008-11-17 | 2011-10-12 | 霍夫曼-拉罗奇有限公司 | 用作crth2拮抗剂或部分激动剂的萘乙酸 |
| MX2011005120A (es) | 2008-11-17 | 2011-05-30 | Hoffmann La Roche | Acidos naftilaceticos. |
| IN2012DN03312A (de) | 2009-10-22 | 2015-10-23 | Fibrotech Therapeutics Pty Ltd | |
| US8470884B2 (en) | 2011-11-09 | 2013-06-25 | Hoffmann-La Roche Inc. | Alkenyl naphthylacetic acids |
| CN102964279B (zh) * | 2012-12-12 | 2014-05-07 | 中国药科大学 | 一类具有外周镇痛作用的κ阿片受体激动剂 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3623941A1 (de) * | 1986-07-16 | 1988-01-28 | Bayer Ag | Substituierte amino-5,6,7,8-tetrahydronaphthyl-oxyessigsaeuren, verfahren zu deren herstellung sowie die verwendung als arzneimittel |
| DE3642105A1 (de) * | 1986-12-10 | 1988-06-16 | Bayer Ag | Substituierte aminomethyl-5,6,7,8-tetrahydronaphtyl-oxyessigsaeuren, neue zwischenprodukte, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
-
1994
- 1994-12-07 EP EP94309088A patent/EP0657422B1/de not_active Expired - Lifetime
- 1994-12-07 DK DK94309088T patent/DK0657422T3/da active
- 1994-12-07 AT AT94309088T patent/ATE167181T1/de not_active IP Right Cessation
- 1994-12-07 ES ES94309088T patent/ES2118333T3/es not_active Expired - Lifetime
- 1994-12-07 DE DE69410956T patent/DE69410956T2/de not_active Expired - Fee Related
- 1994-12-08 KR KR1019940033236A patent/KR100191946B1/ko not_active Expired - Fee Related
- 1994-12-08 US US08/355,187 patent/US5624959A/en not_active Expired - Lifetime
- 1994-12-09 CN CN94112786A patent/CN1111612A/zh active Pending
- 1994-12-09 CA CA002137711A patent/CA2137711A1/en not_active Abandoned
-
1996
- 1996-12-17 US US08/768,291 patent/US5723493A/en not_active Expired - Fee Related
-
1998
- 1998-08-20 GR GR980401871T patent/GR3027694T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0657422B1 (de) | 1998-06-10 |
| CN1111612A (zh) | 1995-11-15 |
| DE69410956T2 (de) | 1999-03-25 |
| CA2137711A1 (en) | 1995-06-10 |
| US5624959A (en) | 1997-04-29 |
| ES2118333T3 (es) | 1998-09-16 |
| DE69410956D1 (de) | 1998-07-16 |
| EP0657422A1 (de) | 1995-06-14 |
| US5723493A (en) | 1998-03-03 |
| DK0657422T3 (da) | 1998-10-12 |
| KR950017941A (ko) | 1995-07-22 |
| GR3027694T3 (en) | 1998-11-30 |
| KR100191946B1 (ko) | 1999-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE167181T1 (de) | Naphthylessigsäurederivate als pgez agonisten und antagonisten | |
| BRPI9908319B1 (pt) | composto amino cìclico, composição farmacêutica, medicamento contendo um composto amino cìclico ou um sal farmacologicamente aceitável do mesmo, e, uso de um composto amino cìclico ou um sal farmacologicamente aceitável do mesmo. | |
| IL87795A (en) | Benzimidazolin-2-oxo- 1-carboxylic acid ester and amide derivatives, their preparation and pharmaceutical compositions containing them | |
| IL147651A0 (en) | Isoxazoline derivative and herbicide containing the same as the active ingredient | |
| DE60232739D1 (de) | Aktivator des peroxisomproliferator-aktivierten rezeptors delta | |
| EA200100755A1 (ru) | 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты | |
| DK283589D0 (da) | 1-indolylalkyl-4-(substitueret pyridinyl)-piperaziner | |
| ES2062009T4 (es) | Agentes antifungicos derivados de triazol | |
| ATE205484T1 (de) | Aminotetrazol-derivate verwendbar als stickstoff- oxid-synthase inhibitoren | |
| DK0625977T3 (da) | Piperazinderivater som 5-1A-antagonister | |
| DE69330639D1 (de) | Methotrexat-derivate | |
| DE69309454D1 (de) | Pyridincarboximidamide und deren anwendung | |
| FI923774A0 (fi) | 1,7-anellerande 2-(piperazinoalkyl) indolderivat samt foerfaranden och mellanprodukter foer deras framstaellning. | |
| DK0505778T3 (da) | Derivater af imidazol-2-oner samt fremgangsmåde til fremstilling deraf | |
| ATE175196T1 (de) | 4-phenyl-3-(heteroarylureido)-1,2-dihydro-2- oxochinolin derivate, als antihypercholesterolemische und antiatherosklerotische mittel | |
| ATE204880T1 (de) | N-acyldipeptide, und pharmazeutische präparate davon | |
| SE8303913L (sv) | Heterocykliska foreningar | |
| IL136510A (en) | Acylated hetero-alicyclic derivatives and pharmaceutical compositions containing the same | |
| SE8101703L (sv) | Nya isoxazolderivat jemte sett for deras framstellning |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |